Basic Study
Copyright ©The Author(s) 2023.
World J Diabetes. Mar 15, 2023; 14(3): 234-254
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.234
Table 1 Primary and secondary antibodies
Antibodies
Company
Dilution
CD31abcam, ab2815831:300 dilution
α-SMAabcam, ab1249641:300 dilution
Caspase-1Servicebio, GB113831:500 dilution
Cleaved-caspase-1Immunoway, YC0021:1000 dilution
NLRP3Immunoway, YT53821:1000 dilution
GSDMDProteintech, 66387-1-l g1:5000 dilution
ICAM-1abcam, ab2227361:1000 dilution
VCAM-1abcam, ab1340471:1000 dilution
eNOSabcam, ab55891:1000 dilution
VEGFabcam, ab529171:5000 dilution
CD45Proteintech, 60287-1-l g1:200 dilution
TNF-αabcam, ab1832181:1000 dilution
VE-cadherinProteintech, 27956-1-AP1:1000 dilution
β-cateninProteintech, 51067-2-AP1:5000 dilution
F4/80Servicebio, GB1133731:500 dilution
iNOSabcam, ab153231:250 dilution
Arg-1Proteintech, 66129-1-l g1:1000 dilution
Jagged-1Immunoway, YT54011:1000 dilution
Notch-1Servicebio, GB1116901:500 dilution
ephrin-B2Immunoway, YT15861:1000 dilution
MMP9Servicebio, GB111321:1000 dilution
MMP2Servicebio, GB111301:1000 dilution
GAPDHServicebio, G3206-1OD1:2000 dilution
α-tubulinServicebio, GB151391:500 dilution
Goat anti-rabbit IgGabcam, ab2167771:5000 dilution
Goat anti-mouse IgG H&LAbcam, ab2167721:5000 dilution
Alexa Flour® 488 goat anti-rabbit IgGServicebio, GB253031:250 dilution
Cy3-conjugated goat Servicebio, GB253031:250 dilution
anti-mouse IgG